Nabriva to refile Contepo application next quarter; shares up 4% premarket [Seeking Alpha]
Nabriva Therapeutics plc - Ordinary Shares (NBRV)
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.nabriva.com/investor-relations
Company Research
Source: Seeking Alpha
Based on feedback from the FDA and the receipt of the minutes from its meeting with the agency, Nabriva Therapeutics (NASDAQ: NBRV ) expects to resubmit its marketing application next quarter for CONTEPO (fosfomycin) for the treatment of complicated urinary tract infections, including acute pyelonephritis. The company received a CRL in April citing deficiencies at one of its contract manufacturers. Shares are up premarket on light volume. See all stocks on the move » Now read: Scholar Rock (SRRK) Presents At Wedbush PacGrow Healthcare Conference - Slideshow » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
NBRV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NBRV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NBRV alerts
High impacting Nabriva Therapeutics plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics